READ-ONLY DIGITIZATION RESULT
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.
N Engl J Med · 2025-Jul-17 · PMID 40513032
Panel Panel_A_GVHD-free_relapse-free_survival_GRFS_提取完成待 EXE 对齐验证
GVHD-free, relapse-free survival (GRFS)
Figure 2.. Kaplan-Meier probability curves by treatment arm for primary and secondary endpoints in the full analysis set. Panel A shows the percent of patients for the primary endpoint of GVHD-free, relapse-free survival (GRFS). Numbers at risk in each group are shown below. Panel B shows the percent of patients for the post-hoc analysis endpoint of relapse-free survival (RFS). Panel C shows the percent of patients for the secondary endpoint of overall survival (OS).
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:03:25+00:00 |